Haase A, Olmer R, Schwanke K, et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell, 2009, 5: 434-441
[2]
Kim J B, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature, 2008,454: 646-650
[3]
Eminli S, Utikal J, Arnold K, et al. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenousSox2 expression. Stem Cells, 2008, 26: 2467-2474
[4]
Park I H, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell, 2008, 134: 877-886
[5]
Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 2008, 321: 699-702
[6]
Aasen T, Raya A, Barrero M J, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol,2008, 26: 1276-1284
[7]
Kim J B, Sebastiano V, Wu G M, et al. Oct4-induced pluripotency in adult neural stem cells. Cell, 2009, 136: 411-419
[8]
Conti L, Pollard S M, Gorba T, et al. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol, 2005, 3: e283
[9]
Taura D, Noguchi M, Sone M, et al. Adipogenic differentiation of human induced pluripotent stem cells: Comparison with that of humanembryonic stem cells. FEBS Lett, 2009, 583: 1029-1033
[10]
Hirami Y, Osakada F, Takahashi K, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett, 2009,458: 126-131
[11]
Gai H, Leung E L, Costantino P D, et al. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cellsderived from human fibroblasts. Cell Biol Int, 2009, 33: 1184-1193
[12]
Dimos J T, Rodolfa K T, Niakan K K, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motorneurons. Science, 2008, 321: 1218-1221
[13]
Wichterle H, Przedborski S. What can pluripotent stem cells teach us about neurodegenerative diseases. Nat Neurosci, 2010, 13: 800-804
[14]
Przedborski S, Vila M, Jackson-Lewis V. Neurodegeneration: What is it and where are we. J Clin Invest, 2003, 111: 3-10
[15]
Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature, 2006, 441: 1094-1096
[16]
Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol, 2005, 23: 862-871
[17]
Rossi F, Cattaneo E. Opinion: Neural stem cell therapy for neurological diseases: Dreams and reality. Nat Rev Neurosci, 2002, 3: 401-409
[18]
Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci, 2000, 3: 537-544
[19]
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006,126: 663-676
[20]
Tat P A, Sumer H, Jones K L, et al. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived andneural stem cells. Cell Transplant, 2010, 19: 525-536
[21]
Giorgetti A, Montserrat N, Rodriguez-Piza I, et al. Generation of induced pluripotent stem cells from human cord blood cells with only twofactors: Oct4 and Sox2. Nat Protoc, 2010, 5: 811-820
[22]
Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol, 2009, 27: 743-745
[23]
Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322: 945-949
[24]
Qin D J, Gan Y, Shao K F, et al. Mouse meningiocytes express Sox2 and yield high efficiency of chimeras after nuclear reprogramming withexogenous factors. J Biol Chem, 2008, 283: 33730-33735
[25]
Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. NatBiotechnol, 2008, 26: 101-106
[26]
Ying Q L, Stavridis M, Griffiths D, et al. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. NatBiotechnol, 2003, 21: 183-186
[27]
Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science,2007, 318: 1920-1923
[28]
Wernig M, Zhao J P, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improvesymptoms of rats with Parkinson’s disease. Proc Natl Acad Sci USA, 2008, 105: 5856-5861
[29]
Hu B Y, Weick J P, Yu J Y, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but withvariable potency. Proc Natl Acad Sci USA, 2010, 107: 4335-4340
[30]
Hayashi H, Morizane A, Koyanagi M, et al. Meningeal cells induce dopaminergic neurons from embryonic stem cells. Eur J Neurosci, 2008, 27:261-268
[31]
Polo J M, Liu S, Figueroa M E, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stemcells. Nat Biotechnol, 2010, 28: 848-855
